SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19. Clemens DJ, Ye D, Zhou W, Kim CSJ, et al. PLoS One 2023;18:e0282151.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Clemens DJ, Ye D, Zhou W, Kim CSJ, et al. SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19. PLoS One 2023;18:e0282151.
PMID: 36888581